Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Goodwill & Intangibles: 2022-2025

Historic Goodwill & Intangibles for InMed Pharmaceuticals (INM) over the last 4 years, with Jun 2025 value amounting to $2.9 million.

  • InMed Pharmaceuticals' Goodwill & Intangibles changed negligibly% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $2.9 million for FY2025, which is negligibly% changed negligibly from last year.
  • Latest data reveals that InMed Pharmaceuticals reported Goodwill & Intangibles of $2.9 million as of FY2025, which was down 0.00% from $2.9 million recorded in FY2024.
  • InMed Pharmaceuticals' 5-year Goodwill & Intangibles high stood at $4.0 million for FY2023, and its period low was $2.1 million during FY2022.
  • For the 3-year period, InMed Pharmaceuticals' Goodwill & Intangibles averaged around $3.3 million, with its median value being $2.9 million (2025).
  • In the last 5 years, InMed Pharmaceuticals' Goodwill & Intangibles spiked by 89.91% in 2023 and then dropped by 26.90% in 2024.
  • Yearly analysis of 4 years shows InMed Pharmaceuticals' Goodwill & Intangibles stood at $2.1 million in 2022, then surged by 89.91% to $4.0 million in 2023, then dropped by 26.90% to $2.9 million in 2024, then remained steady at $2.9 million in 2025.